BIOLIFE SOLUTIONS INC (BLFS) Stock Income Statement
NASDAQ:BLFS - Nasdaq - US09062W2044 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 94.24M | 82.25M | 75.86M | 161.80M | 119.20M | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | N/A | |||
| Cost Of Goods | 35.20M | 28.58M | 29.92M | 107.90M | 82.10M | |||
| Gross Profit | 59.04M | 53.67M | 45.93M | 53.80M | 37.00M | |||
| Operating Expenses | 63.23M | 60.80M | 69.37M | 89.00M | 70.60M | |||
| Research and Development | 7.72M | 7.91M | 12.07M | 14.80M | 11.80M | |||
| Selling, General, and Administrative Expenses | 49.98M | 50.15M | 55.97M | 69.20M | 47.70M | |||
| Operating Income | -4.19M | -7.13M | -23.44M | -35.10M | -33.50M | |||
| Interest Income/Expense | -3.94M | -4.79M | -1.45M | 0.00 | -500.00K | |||
| Other Income/Expense | 362.00K | 497.00K | 1.30M | 700.00K | 200.00K | |||
| Non Recurring Items | N/A | 0.00 | 5.12M | -110.40M | 4.80M | |||
| Income Before Taxes | -7.77M | -11.43M | -18.47M | -144.80M | -29.00M | |||
| Income Tax | -145.00K | -38.00K | -24.00K | -5.00M | -20.10M | |||
| Net Income | -10.41M | -20.18M | -68.00M | -139.80M | -8.90M | |||
| EBITDA | 3.58M | 1.53M | -11.14M | -18.62M | -20.64M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.24 | -0.43 | -1.55 | -3.29 | -0.23 | |||
| Non GAAP EPS | -0.29 | -0.51 | -1.15 | -1.61 | -0.52 | |||
| Statistics | ||||||||
| Gross Profit Margin | 62.64% | 65.25% | 60.55% | 33.25% | 31.04% | |||
| Profit Margin | -11.05% | -24.54% | -89.65% | -86.40% | -7.47% | |||
| Operating Profit Margin | -4.44% | -8.67% | -30.90% | -21.69% | -28.10% | |||
All data in USD